Oconmed
3 known investors
OCON Therapeutics develops intrauterine drug-delivery products based on its IUB platform, including a hormone-free IUD contraceptive, an endometrial ablation device for abnormal and heavy menstrual bleeding, and a therapeutic-delivery device targeting conditions such as endometriosis and myomas. The company focuses on women's health, delivering treatments directly through the uterus to avoid systemic side effects.
BiotechFemTechMedical Devices
Investors · 3
Frequently asked questions
- What does Oconmed do?
- OCON Therapeutics develops intrauterine drug-delivery products based on its IUB platform, including a hormone-free IUD contraceptive, an endometrial ablation device for abnormal and heavy menstrual bleeding, and a therapeutic-delivery device targeting conditions such as endometriosis and myomas. The company focuses on women's health, delivering treatments directly through the uterus to avoid systemic side effects.
- Who are Oconmed's investors?
- Oconmed's investors include Astia, Foreground Capital, Pontifax Venture Capital.